Regulatory Affairs Specialist at Enterprise
High Conscientiousness and Openness to manage registration dossiers, engage regulatory agencies, and anticipate regulatory changes across LATAM.
In enterprise pharma, multi-market regulatory complexity is the norm
10-15 year development cycles require genuine long-term vision
Pharmacovigilance and patient safety are non-delegable responsibilities
Ideal OCEAN+ Profile
At enterprise companies (201-1000 employees), ability to interpret complex regulations, identify precedents, and design registration strategies in response to regulatory changes across LATAM
At enterprise companies (201-1000 employees), absolute precision in preparing dossiers, tracking regulatory deadlines, and keeping registration documentation current
At enterprise companies (201-1000 employees), ability to engage with regulatory authorities and represent the company's position before agencies such as COFEPRIS, ANMAT, or ANVISA
At enterprise companies (201-1000 employees), collaboration with quality, medical, legal, and marketing teams to align registration strategies with business needs
At enterprise companies (201-1000 employees), managing stress under immovable regulatory deadlines, agency queries, and the risk of product unavailability
At enterprise companies (201-1000 employees), regulatory Affairs operates on defined submission procedures, ICH/FDA/EMA guidelines, and agency response timelines; any deviation from the submission process can result in rejection, delay, or regulatory sanction
Strengths and Red Flags
Strengths
- Preparing and managing registration dossiers with a high first-round approval rate
- Interpreting local and international regulations (ICH, CTD, eCTD)
- Managing product portfolios across multiple development and commercialization phases
- Robust regulatory compliance with FDA, EMA, and local health authorities
Red Flags
- Superficial dossier review that generates avoidable agency queries
- Regulatory knowledge gaps that lead to strategies based on outdated rules
- Paralysis in the face of complex multi-product, multi-phase portfolios
- Internal bureaucracy that delays go/no-go pipeline decisions
Interview Questions
What was the most complex registration dossier you prepared? What queries did you get from the agency, and how did you respond to them?
Evaluates: Conscientiousness and handling complex regulatory interactions
Describe how you monitor regulatory changes in the countries in your portfolio. Give me an example of a recent change you anticipated and how it affected the business.
Evaluates: Openness and proactive regulatory intelligence
How did you manage a multi-product portfolio across different development phases?
Evaluates: Systemic vision and prioritization capacity at scale
How did you coordinate a multi-market regulatory registration process?
Evaluates: Conscientiousness and coordination in highly complex environments
More about Regulatory Affairs Specialist
Career path, personality archetypes and similar roles in the full profile.
This Role in Other Contexts
Regulatory Affairs Specialist — base profile with no company context
View profile → Startup (1-50 employees)In pharma startups, time to regulatory approval defines survival
View profile → SMB (51-200 employees)In SMB pharma, quality and compliance are the license to operate
View profile → Global (1001+ employees)Global pharma means registrations in dozens of markets with different requirements
View profile →Does your next Regulatory Affairs Specialist at Enterprise (201-1000 employees) match this profile?
Map anyone's OCEAN+ profile with the Talent Diagnostic: free, no signup, 10 minutes.
20 statements · 10 minutes · no card